China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering
PR Newswire•08/10/2026•09:23 ET
0
Key Highlights
- ➤$12 million registered direct offering priced at $1.50 per Class A share
- ➤8 million warrants issued, exercisable at $1.50 for one year
- ➤Investors can purchase an additional $12 million during 30 days
- ➤Offering expected to close around October 9, 2026
China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering PR Newswire
TAIZHOU, China, Oct. 8, 2026 /PRNewswire/ -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the "Company"), today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale of an aggregate of 8,000,000 Class A ordinary shares of the company, no par value per share (the "Shares") (or pre-funded warrants in lieu thereof), at a purchase price of $1.50 per share in a registered direct offering.
Get started
Create a free account to read the full story.